Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

3.

[From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].

Reitsma PH, van de Stolpe A.

Ned Tijdschr Geneeskd. 2001 Sep 22;145(38):1843-5. Review. Dutch.

PMID:
11593787
5.

Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.

De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G.

Semin Thromb Hemost. 2000;26(3):305-11. Review.

PMID:
11011848
6.

The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy.

Welker GC, Lookinland S, Tiedeman ME, Beckstrand RL.

J Am Acad Nurse Pract. 2004 Mar;16(3):106-15, 138. Review.

PMID:
15130065
7.

Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.

Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW.

Arch Intern Med. 2006 Apr 10;166(7):729-36. Review.

PMID:
16606808
8.

The molecular mechanisms of inherited thrombophilia.

März W, Nauck M, Wieland H.

Z Kardiol. 2000 Jul;89(7):575-86. Review.

PMID:
10957782
9.

Epidemiology of factor V Leiden: clinical implications.

De Stefano V, Chiusolo P, Paciaroni K, Leone G.

Semin Thromb Hemost. 1998;24(4):367-79. Review.

PMID:
9763354
10.

Screening for inherited thrombophilia: indications and therapeutic implications.

De Stefano V, Rossi E, Paciaroni K, Leone G.

Haematologica. 2002 Oct;87(10):1095-108. Review.

11.

Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics.

Bauduer F, Lacombe D.

Mol Genet Metab. 2005 Sep-Oct;86(1-2):91-9. Epub 2005 Sep 26. Review.

PMID:
16185908
12.

Thrombophilia and risk of venous thrombosis in patients with cancer.

Decousus H, Moulin N, Quenet S, Bost V, Rivron-Guillot K, Laporte S, Mismetti P.

Thromb Res. 2007;120 Suppl 2:S51-61. Review. Erratum in: Thromb Res. 2008;123(1):187-90.

PMID:
18023713
13.

The prothrombin 20210 G to A variation and thrombosis.

Bertina RM.

Curr Opin Hematol. 1998 Sep;5(5):339-42. Review.

PMID:
9776213
14.

Arterial thrombosis and the role of thrombophilia.

Boekholdt SM, Kramer MH.

Semin Thromb Hemost. 2007 Sep;33(6):588-96. Review.

PMID:
17768691
15.

The prothrombin gene variant 20210A in venous and arterial thromboembolism.

Vicente V, González-Conejero R, Rivera J, Corral J.

Haematologica. 1999 Apr;84(4):356-62. Review.

16.

[Genetic risk factors of venous thromboembolism].

Oner F, Kaya A, Doğan R, Numanoğlu N.

Tuberk Toraks. 2003;51(1):60-9. Review. Turkish.

PMID:
15100907
17.
18.

Issues concerning the laboratory investigation of inherited thrombophilia.

Tripodi A.

Mol Diagn. 2005;9(4):181-6. Review.

PMID:
16392896
19.

The thrombophilias: well-defined risk factors with uncertain therapeutic implications.

Bauer KA.

Ann Intern Med. 2001 Sep 4;135(5):367-73. Review.

PMID:
11529700
20.

Thrombophilia, polymorphisms, and vascular disease.

Sykes TC, Fegan C, Mosquera D.

Mol Pathol. 2000 Dec;53(6):300-6. Review.

Supplemental Content

Support Center